ADAR1 Capital Management »

Amplify Energy Corp shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Amplify Energy Corp (AMPY) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Amplify Energy Corp

Tip: Access up to 7 years of quarterly data

All positions including Amplify Energy Corp held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amplify Energy Corp by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $42k 7.1k 5.93

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Roivant Sciences SHS (ROIV)
Cytokinetics Com New (CYTK)
Arbutus Biopharma (ABUS)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Cerevel Therapeutics Hldng I (CERE)
Mirati Therapeutics
Merck & Co (MRK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Immunovant (IMVT)
Viking Therapeutics (VKTX)
Protagonist Therapeutics (PTGX)

View all positions for ADAR1 Capital Management

Top funds holding Amplify Energy Corp

Vanguard Group
Dimensional Fund Advisors
AQR Capital Management
Foundry Partners
Citadel Advisors
Bank of New York Mellon
PanAgora Asset Management
Yacktman Asset Management
Wolverine Trading
Rhumbline Advisers
Connor, Clark & Lunn Investment Management
Martingale Asset Management
Federated Investors
Charles Schwab Investment Management
Dalton Investments

View all funds holding Amplify Energy Corp